Palisade Bio, Inc.
PALI
$2.14
-$0.01-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 174.23% | 90.54% | 35.68% | -11.59% | -15.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 195.59% | 96.31% | 21.52% | -20.47% | -16.88% |
| Operating Income | -191.47% | -96.31% | -21.52% | 20.47% | 16.88% |
| Income Before Tax | -169.66% | -83.78% | -16.23% | 20.18% | 16.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -169.66% | -83.78% | -16.23% | 20.18% | 16.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -169.66% | -83.78% | -16.23% | 20.18% | 16.43% |
| EBIT | -191.47% | -96.31% | -21.52% | 20.47% | 16.88% |
| EBITDA | -191.52% | -96.33% | -21.52% | 20.47% | 16.88% |
| EPS Basic | 89.37% | 86.25% | 87.51% | 80.22% | 75.54% |
| Normalized Basic EPS | 89.37% | 86.25% | 87.51% | 79.73% | 75.04% |
| EPS Diluted | 89.37% | 86.25% | 87.51% | 80.22% | 75.54% |
| Normalized Diluted EPS | 89.37% | 86.25% | 87.51% | 79.73% | 75.04% |
| Average Basic Shares Outstanding | 4,684.05% | 4,313.85% | 3,834.89% | 367.28% | 327.01% |
| Average Diluted Shares Outstanding | 4,684.05% | 4,313.85% | 3,834.89% | 367.28% | 327.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |